Technical Analysis for FLGT - Fulgent Genetics, Inc.

Grade Last Price % Change Price Change
F 83.16 3.16% 2.55
FLGT closed up 3.32 percent on Monday, October 18, 2021, on 63 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Nov 8
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical FLGT trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 3.16%
Bullish Engulfing Bullish 3.16%
Stochastic Reached Oversold Weakness 3.16%
Multiple of Ten Bullish Other 3.16%
Oversold Stochastic Weakness 3.16%
Multiple of Ten Bearish Other 6.59%
20 DMA Resistance Bearish 5.71%
Death Cross Bearish 5.71%
180 Bearish Setup Bearish Swing Setup 5.71%
Multiple of Ten Bearish Other 5.71%
Older End-of-Day Signals for FLGT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% about 3 hours ago
Up 2% about 3 hours ago
Rose Above Previous Day's High about 3 hours ago
Rose Above 10 DMA about 3 hours ago
Up 1% about 3 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fulgent Genetics, Inc. Description

Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Cancers Genetics Medical Genetics Cardiovascular Disease Medical Tests Neurological Disorders Algorithms Molecular Diagnostics Vascular Diseases Cardiovascular Diseases Applied Genetics Urological Disorders Genetic Testing Adaptive Learning Qiagen Alternatives To Animal Testing

Is FLGT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 189.8899
52 Week Low 30.05
Average Volume 522,535
200-Day Moving Average 90.56
50-Day Moving Average 89.07
20-Day Moving Average 83.83
10-Day Moving Average 80.76
Average True Range 4.63
ADX 11.49
+DI 19.16
-DI 26.15
Chandelier Exit (Long, 3 ATRs) 80.51
Chandelier Exit (Short, 3 ATRs) 89.56
Upper Bollinger Bands 92.42
Lower Bollinger Band 75.23
Percent B (%b) 0.31
BandWidth 20.50
MACD Line -2.60
MACD Signal Line -2.45
MACD Histogram -0.1521
Fundamentals Value
Market Cap 1.96 Billion
Num Shares 24.3 Million
EPS 2.14
Price-to-Earnings (P/E) Ratio 37.67
Price-to-Sales 7.56
Price-to-Book 5.95
PEG Ratio 1.32
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 86.50
Resistance 3 (R3) 86.08 83.70 85.52
Resistance 2 (R2) 83.70 82.19 83.91 85.19
Resistance 1 (R1) 82.15 81.27 82.92 82.57 84.87
Pivot Point 79.77 79.77 80.15 79.98 79.77
Support 1 (S1) 78.22 78.27 79.00 78.65 76.35
Support 2 (S2) 75.84 77.34 76.05 76.03
Support 3 (S3) 74.29 75.84 75.70
Support 4 (S4) 74.72